Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients
Giulia Radi, Oriana Simonetti, Giulio Rizzetto, et al.
Healthcare (2021) Vol. 9, Iss. 11, pp. 1575-1575
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
Federico Diotallevi, Helena Gioacchini, Edoardo De Simoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4910-4910
Open Access | Times Cited: 40
Optimizing topical management of atopic dermatitis
Sneha Butala, Amy S. Paller
Annals of Allergy Asthma & Immunology (2022) Vol. 128, Iss. 5, pp. 488-504
Open Access | Times Cited: 32
Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations
Sneha Butala, Leslie Castelo‐Soccio, Rishi Seshadri, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1361-1373
Open Access | Times Cited: 21
Role of antioxidants supplementation in the treatment of atopic dermatitis: a critical narrative review
Edoardo De Simoni, Matteo Candelora, Sara Belleggia, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 6
Canthaxanthin ameliorates atopic dermatitis in mice by suppressing Th2 immune response
Shuying Peng, Lu Yu, Ming Jiang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113975-113975
Closed Access
Treatment advances in Vitiligo: An Updated Review
Ishrat Binti Ismail, Yasmeen Jabeen Bhat, Mohd Shurjeel Ul Islam
Dermatology Practical & Conceptual (2025) Vol. 15, Iss. 1, pp. 4600-4600
Open Access
Baricitinib in the Treatment of Severe Atopic Dermatitis Resistant to Cyclosporine: A Case Report Involving Two Cases
Abhishek De, Sk Shahriar Ahmed, Disha Chakraborty, et al.
Cureus (2025)
Open Access
Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
Negar Beirampour, Mireia Mallandrich, Paola Bustos-Salgado, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 475-475
Open Access
Genetic/Environmental Contributions and Immune Dysregulation in Children with Atopic Dermatitis
Albert C. Chong, Kittipos Visitsunthorn, Peck Y. Ong
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 1681-1700
Open Access | Times Cited: 21
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial
M. Waibel, Helen E. Thomas, John M. Wentworth, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Qin Gao, Yanxia Zhao, Junling Zhang
Heliyon (2023) Vol. 9, Iss. 6, pp. e16704-e16704
Open Access | Times Cited: 12
Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases
Tong Li, Xianjing Yang, Juan Zhu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110660-110660
Closed Access | Times Cited: 12
Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16
Jacob P. Thyssen, Marjolein de Bruin‐Weller, Antonio Costanzo, et al.
Advances in Therapy (2023) Vol. 40, Iss. 8, pp. 3574-3587
Open Access | Times Cited: 11
Impact of upadacitinib induction and maintenance therapy on health-related quality of life, fatigue, and work productivity in patients with moderately-to-severely active Crohn’s disease
Subrata Ghosh, Brian G. Feagan, Rogério Serafim Parra, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 4
SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
Martina Morelli, Stefania Madonna, Cristina Albanesi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
Yozahandy A Abarca, Renee Scott-Emuakpor, Jhanavi Tirth, et al.
Cureus (2025)
Open Access
Successful treatment of refractory prurigo nodularis with baricitinib
Mengting Yin, Ruimiao Wu, Jiaying Chen, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 8
Open Access | Times Cited: 17
Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment
Caitlin Thomas, Afaf Raibouaa, Andreas Wollenberg, et al.
BMJ Open (2022) Vol. 12, Iss. 8, pp. e058799-e058799
Open Access | Times Cited: 15
Janus Kinase Inhibitors: A Promising Therapeutic Option for Allergic Contact Dermatitis
Hadley Johnson
Cutis (2023) Vol. 111, Iss. 2
Open Access | Times Cited: 7
Innovative Immunotherapy for the Treatment of Atopic Dermatitis: Focus on the European and Latin American Regulatory Frameworks
Francesco Ferrara, Andrea Zovi, Maurizio Capuozzo, et al.
Current Dermatology Reports (2024) Vol. 13, Iss. 2, pp. 55-66
Closed Access | Times Cited: 2
TYK2 as a novel therapeutic target in psoriasis
Sarah Elyoussfi, Shraddha S. Rane, Stephen Eyre, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 6, pp. 549-558
Closed Access | Times Cited: 6
Treatment-resistant atopic dermatitis: novel therapeutics, digital tools, and precision medicine
Piyu Parth Naik
Asia Pacific Allergy (2022) Vol. 12, Iss. 2, pp. e20-e20
Open Access | Times Cited: 10
A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria
Atsuyuki Igarashi, Akira Yuasa, Naohiro Yonemoto, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 8, pp. 1729-1751
Open Access | Times Cited: 9
Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement
Carmela Giancotta, Nicole Colantoni, Lucia Pacillo, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 5
How to Understand Personalized Medicine in Atopic Dermatitis Nowadays?
Alicja Mesjasz, Karol Kołkowski, Andreas Wollenberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7557-7557
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top